Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Nov 7;12(1):18872.
doi: 10.1038/s41598-022-23488-z.

A bioinformatics approach to the identification of novel deleterious mutations of human TPMT through validated screening and molecular dynamics

Affiliations

A bioinformatics approach to the identification of novel deleterious mutations of human TPMT through validated screening and molecular dynamics

Sidharth Saxena et al. Sci Rep. .

Abstract

Polymorphisms of Thiopurine S-methyltransferase (TPMT) are known to be associated with leukemia, inflammatory bowel diseases, and more. The objective of the present study was to identify novel deleterious missense SNPs of TPMT through a comprehensive in silico protocol. The initial SNP screening protocol used to identify deleterious SNPs from the pool of all TPMT SNPs in the dbSNP database yielded an accuracy of 83.33% in identifying extremely dangerous variants. Five novel deleterious missense SNPs (W33G, W78R, V89E, W150G, and L182P) of TPMT were identified through the aforementioned screening protocol. These 5 SNPs were then subjected to conservation analysis, interaction analysis, oncogenic and phenotypic analysis, structural analysis, PTM analysis, and molecular dynamics simulations (MDS) analysis to further assess and analyze their deleterious nature. Oncogenic analysis revealed that all five SNPs are oncogenic. MDS analysis revealed that all SNPs are deleterious due to the alterations they cause in the binding energy of the wild-type protein. Plasticity-induced instability caused by most of the mutations as indicated by the MDS results has been hypothesized to be the reason for this alteration. While in vivo or in vitro protocols are more conclusive, they are often more challenging and expensive. Hence, future research endeavors targeted at TPMT polymorphisms and/or their consequences in relevant disease progressions or treatments, through in vitro or in vivo means can give a higher priority to these SNPs rather than considering the massive pool of all SNPs of TPMT.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Figure 1
Figure 1
Visual representation of the methodology followed in the present study (The rectangle on the top right represents the pool of all TPMT SNPs. Please refer to Figure S1 for more details).
Figure 2
Figure 2
Accuracy of the in silico screening pipeline with respect to the pre-identified deleterious missense mutations of human TPMT.
Figure 3
Figure 3
RMSD, RMSF, Rg and H-bond analysis results.
Figure 4
Figure 4
SASA analysis and PCA results.
Figure 5
Figure 5
Ligand conformations for all six ligand-bound systems across 0, 20, 40, 60, 80 and 100 ns of simulation time.
Figure 6
Figure 6
The relative deleterious nature of the five highly deleterious TPMT missense SNPs. A score of 100 for a mutation in a particular category indicates that the given mutation is the most deleterious with respect to that category (SQBT = Sequence-based tools, SRBT = Structure-based tools, BPI score = Binding pocket impact score, AFR = Amyloid forming region, PTM = Post-translational modification, MDS = Molecular dynamics simulations).

References

    1. Elion GB, Hitchings GH. The synthesis of 6-thioguanine. J. Am. Chem. Soc. 1955;77(6):1676. doi: 10.1021/ja01611a082. - DOI
    1. Zakerska-Banaszak O, Łykowska-Szuber L, Walczak M, Żuraszek J, Zielińska A, Skrzypczak-Zielińska M. Cytotoxicity of thiopurine drugs in patients with inflammatory bowel disease. Toxics. 2022;10(4):151. doi: 10.3390/toxics10040151. - DOI - PMC - PubMed
    1. Bayoumy AB, Crouwel F, Chanda N, Florin TH, Buiter HJ, Mulder CJ, de Boer NK. Advances in thiopurine drug delivery: the current state-of-the-art. Eur. J. Drug Metab. Pharmacokinet. 2021;46(6):743–758. doi: 10.1007/s13318-021-00716-x. - DOI - PMC - PubMed
    1. Coulthard SA, McGarrity S, Sahota K, Berry P, Redfern CPF. Three faces of mercaptopurine cytotoxicity in vitro: methylation, nucleotide homeostasis, and deoxythioguanosine in DNA. Drug Metab. Disposit. Biol. Fate Chem. 2018;46(8):1191–1199. doi: 10.1124/dmd.118.081844. - DOI - PubMed
    1. Brookes AJ. The essence of SNPs. Gene. 1999;234(2):177–186. doi: 10.1016/S0378-1119(99)00219-X. - DOI - PubMed